This precise targeting mechanism leads to the degradation of MYC protein through the ubiquitin E3-ligase STUB1-mediated 26S proteasome pathway, ultimately inducing apoptosis in cancer cells and highlighting its significant role in cancer treatment [86]. This evidence concerns the gene MYC and cancer.